Upcoming Events

There are no upcoming events at this time.

Register Today!

Get Free Test Access

Using RbM to Evaluate Site Engagement

Using RbM to Evaluate Site Engagement

Case Study

Clinical trial site engagement has been advocated as a critical component relating to a study’s performance and success, however, a minimum amount of data supports this connection.

In this article a reader will find quantitative and qualitative approach based on risk-based monitoring (RbM) to assess study site engagement, develop monitoring risk tool-kits and strategies for specific countries and regions. The authors answer the question: “What can study teams do to mitigate pre-inherent site engagement risks in large trials?”

Download the Case Study

Cyntegrity Clinical Site Engagement

By | 2016-11-16T18:35:46+00:00 March 24, 2015|Case Study|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment